Skip to content

The Effects of Hydromorphone on Responses to Verbal Tasks

The Effects of Hydromorphone on Responses to Verbal Tasks

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02205983
Acronym
HESS
Enrollment
50
Registered
2014-08-01
Start date
2015-01-31
Completion date
2016-09-30
Last updated
2018-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy

Keywords

enrolling, adult, volunteers

Brief summary

In this study, the investigators will examine the effects of hydromorphone, as compared to placebo, upon physiological, subjective, and hormonal responses to a stressful speech task and a non-stressful control task in healthy adults. There is strong evidence in support of the role of endogenous opioids and opiates in mediating social behavior in humans and other animals, and particularly, in social distress. The investigators have recently shown that buprenorphine, a partial mu-opioid agonist, reduces cortisol responses to stress. Here, the investigators propose to further explore the role of the opioid system in mediating stress responses in humans through the use of hydromorphone, a full mu opioid agonist, in addition to acetaminophen. The investigators hypothesize that like acetaminophen, hydromorphone will reduce both physiological and subjective measures of stress.

Detailed description

Participants be randomly assigned to receive 1000 mg acetaminophen, 2mg hydromorphone, 4mg hydromorphone, or placebo at each of two sessions; one during which they well participate in a stressful speaking task, and one during which they'll participate in a nonstressful control task. Physiological and subjective measures will be taken throughout each session.

Interventions

DRUG2 mg hydromorphone

We are administering oral hydromorphone to healthy volunteers to measure its effects on the performance of a verbal task.

We are administering sublingual buprenorphine to healthy volunteers to measure its effects on the performance of a verbal task.

DRUG4 mg hydromorphone

We are administering oral hydromorphone to healthy volunteers to measure its effects on the performance of a verbal task.

DRUGdextrose

We are administering dextrose to healthy volunteers for our placebo group.

Sponsors

National Institute on Drug Abuse (NIDA)
CollaboratorNIH
University of Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Healthy adult volunteers

Exclusion criteria

1. any current medical condition requiring medication or abnormal electrocardiogram 2. current or past medical condition considered to be a contraindication for the study conditions 3. any current Axis I psychiatric disorder (APA, 1994) including Substance Use Disorder, or Anxiety Disorder or Major Depression in the past year, any history of psychosis 4. less than high school education 5. lack of fluency in English 6. night shift work 7. Pregnancy, lactation or plans to become pregnant. 8. Use of hormonal contraception. 9. Daily cigarette smokers i.e., \>7 cigarettes per week

Design outcomes

Primary

MeasureTime frameDescription
Subjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireEnd of study (time 0 and approximately 4 weeks later), week 4 reported.The Drug Effects Questionnaire (DEQ) is a visual analog scale questionnaire that assesses the extent to which subjects experience four subjective states: Feel Drug, Feel High, Like Drug, and Want More. The Feel Drug, Feel High, Like Drug, and Want More subscales are reported. All subscales are scored on a visual analogue scale (scroll bar on computer screen) ranging from 0-100. 100 represents the highest score for that subjective state, and the higher the score, the worse the outcome. The values shown below are only from week 4

Countries

United States

Participant flow

Pre-assignment details

Participants were excluded if they had a serious medical condition, abnormal electrocardiogram, Axis I psychiatric disorder in the past year, or a history of psychosis. Subjects were also excluded if they had not completed high school, were not fluent in English, worked a night shift, used hormonal contraceptives, or were pregnant.

Participants by arm

ArmCount
2 mg Hydromophone
Healthy adult volunteers will receive 2 mg hydromophone. Hydromorphone is a mu-opioid agonist used clinically for pain management. Plasma concentrations of hydromorphone peak approximately 60 min after ingestion.
12
4 mg Hydromorphone
Healthy adult volunteers will receive 4 mg hydromophone. Hydromorphone is a mu-opioid agonist used clinically for pain management. Plasma concentrations of hydromorphone peak approximately 60 min after ingestion
12
1000 mg Acetaminophen
Healthy adult volunteers will receive 1000 mg acetaminophen. Acetaminophen is a COX inhibitor that is used clinically as an analgesic and antipyretic. The dose administered here has been shown to reduce neural and subjective responses to social rejection, and it also peaks about 60 min after ingestion.
13
Dextrose (Placebo)
Healthy adult volunteers will receive Dextrose (placebo).
13
Total50

Baseline characteristics

Characteristic2 mg Hydromophone4 mg Hydromorphone1000 mg AcetaminophenDextrose (Placebo)Total
Age, Continuous19.9 years
STANDARD_DEVIATION 1.8
21.2 years
STANDARD_DEVIATION 2.8
23.6 years
STANDARD_DEVIATION 6.6
23.1 years
STANDARD_DEVIATION 4.4
22 years
STANDARD_DEVIATION 4.5
Region of Enrollment
United States
12 participants12 participants13 participants13 participants50 participants
Sex: Female, Male
Female
4 Participants4 Participants6 Participants5 Participants19 Participants
Sex: Female, Male
Male
8 Participants8 Participants7 Participants8 Participants31 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 120 / 120 / 130 / 13
other
Total, other adverse events
0 / 120 / 120 / 130 / 13
serious
Total, serious adverse events
0 / 120 / 120 / 130 / 13

Outcome results

Primary

Subjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects Questionnaire

The Drug Effects Questionnaire (DEQ) is a visual analog scale questionnaire that assesses the extent to which subjects experience four subjective states: Feel Drug, Feel High, Like Drug, and Want More. The Feel Drug, Feel High, Like Drug, and Want More subscales are reported. All subscales are scored on a visual analogue scale (scroll bar on computer screen) ranging from 0-100. 100 represents the highest score for that subjective state, and the higher the score, the worse the outcome. The values shown below are only from week 4

Time frame: End of study (time 0 and approximately 4 weeks later), week 4 reported.

ArmMeasureGroupValue (MEAN)Dispersion
2 mg HydromophoneSubjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireFeel Drug7.41 units on a scaleStandard Deviation 1.2
2 mg HydromophoneSubjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireLike Drug25.9 units on a scaleStandard Deviation 1.8
2 mg HydromophoneSubjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireFeel High6.08 units on a scaleStandard Deviation 1.5
2 mg HydromophoneSubjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireWant More8.0 units on a scaleStandard Deviation 2.1
4 mg HydromphoneSubjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireLike Drug35.58 units on a scaleStandard Deviation 2.5
4 mg HydromphoneSubjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireFeel High10.33 units on a scaleStandard Deviation 1.01
4 mg HydromphoneSubjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireWant More26.83 units on a scaleStandard Deviation 1.5
4 mg HydromphoneSubjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireFeel Drug14.75 units on a scaleStandard Deviation 1.9
1000 mg AcetaminophenSubjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireFeel High15 units on a scaleStandard Deviation 1.8
1000 mg AcetaminophenSubjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireLike Drug9.61 units on a scaleStandard Deviation 2.2
1000 mg AcetaminophenSubjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireWant More7.38 units on a scaleStandard Deviation 1.96
1000 mg AcetaminophenSubjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireFeel Drug28 units on a scaleStandard Deviation 1.5
DextroseSubjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireWant More2.65 units on a scaleStandard Deviation 1.5
DextroseSubjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireLike Drug4.15 units on a scaleStandard Deviation 1.4
DextroseSubjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireFeel Drug5.76 units on a scaleStandard Deviation 1.1
DextroseSubjective Effects as Assessed by Score on Feel Drug, Feel High, Like Drug, and Want More Subscales of the Drug Effects QuestionnaireFeel High2.61 units on a scaleStandard Deviation 1.8

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026